{"id":207585,"date":"2026-11-17T22:11:09","date_gmt":"2026-11-17T22:11:09","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/207585\/"},"modified":"2026-11-17T22:11:09","modified_gmt":"2026-11-17T22:11:09","slug":"glp-1s-help-kids-slim-down-but-may-slow-growth","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/207585\/","title":{"rendered":"GLP-1s Help Kids Slim Down But May Slow Growth"},"content":{"rendered":"<p class=\"storyParagraph\">&#13;<br \/>\n                                        Weight loss injections are inching their way into elementary schools. New data presented at an obesity conference this week show that Novo Nordisk&#8217;s Wegovy cut body mass index by an average of 13.5% in kids ages 6 to 11, while a diet-and-exercise-only group saw BMI tick up roughly 3%, reports the <a href=\"https:\/\/www.wsj.com\/health\/pharma\/weight-loss-drugs-for-elementary-age-children-succeed-in-study-1718741e?mod=hp_lead_pos11\" rel=\"nofollow noopener\" target=\"_blank\">Wall Street Journal<\/a>. However, children on Wegovy grew about 1.3 inches less than peers not taking the drug, raising questions about long-term height and development that researchers say could take years to answer. Eli Lilly&#8217;s Zepbound lowered BMI by about 18.5% in adolescents and didn&#8217;t appear to slow growth.&#13;\n                                    <\/p>\n<p class=\"storyParagraph\">&#13;<br \/>\n                                        Both drugs improved blood sugar and some cholesterol, but they caused nausea and vomiting in many, and up to 17% of trial participants quit. With nearly 1 in 5 US children considered obese, experts are split on whether the benefits justify the unknowns. &#8220;The question is: Is this the right thing to do?&#8221; says UC San Francisco pediatrics professor Robert Lustig, per the <a href=\"https:\/\/www.nytimes.com\/2026\/11\/16\/well\/weight-loss-drugs-children.html\" rel=\"nofollow noopener\" target=\"_blank\">New York Times<\/a>. &#8220;Not: Does it work? Of course it works. But is it the right thing?&#8221; The World Health Organization recently issued guidance recommending against using such weight loss meds in kids 9 and under, per <a href=\"https:\/\/www.forbes.com\/sites\/maryroeloffs\/2026\/10\/07\/who-recommends-against-glp-1s-for-young-kids-amid-wegovy-trial-for-6-year-olds\/\" rel=\"nofollow noopener\" target=\"_blank\">Forbes<\/a>. <a href=\"https:\/\/politifact.com\/article\/2026\/oct\/05\/glp1-weight-loss-children-obesity-risks-parents\/\" rel=\"nofollow noopener\" target=\"_blank\">PolitiFact<\/a> lays out seven things parents should know before putting their children on GLP-1 meds.&#13;\n                                    <\/p>\n","protected":false},"excerpt":{"rendered":"&#13; Weight loss injections are inching their way into elementary schools. New data presented at an obesity conference&hellip;\n","protected":false},"author":2,"featured_media":207586,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[36596,15247,5769,276,3335,272,357,1910,1165,3103],"class_list":["post-207585","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-adolescents","tag-bmi","tag-children","tag-eli-lilly","tag-glp-1","tag-novo-nordisk","tag-obesity","tag-wegovy","tag-weight-loss-medication","tag-zepbound"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117634077980387944","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/207585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=207585"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/207585\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/207586"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=207585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=207585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=207585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}